A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

This is a prospective, longitudinal, observational study. Current understanding of chronic graft versus host disease (cGVHD) is mostly based on studies that gather information from registries or from single institutions. This study aims to address these challenges by using a hybrid model that includes different types of transplant centers and takes into account the needs of the patients. The goal is to have a more representative group of participants in our study on post-stem cell transplantation.

In order to participate you must meet the following criteria:

• Are 18 years of age or older, inclusive at the time of signing the ICF.
• Have allogeneic SCT 90 to 180 days prior to enrollment.
• Are able to comprehend and willing to provide informed consent.
• Are willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.